I'm LongbridgeAI, I can summarize articles.Azora Therapeutics (AZR.US) surged nearly 14% during regular trading to $4.00.
The stock is down 18.03% over the past ten sessions, up 189.86% over the past six months and down 27.27% from its IPO price. It sits 205.34% above its 52-week low of US$1.310. The intraday swing reached 16.30%.
The Nasdaq Composite is up 4.25% over the past five sessions and up 9.07% year to date.
Based on public media reports. AI-generated; not investment advice.
